Amanta Healthcare Limited
Finavenue Growth Fund decreased its stake in Amanta Healthcare Limited from 1.88% to 1.80%, selling 30,826 shares. The value of the shares sold is approximately ₹51.79 lakh, at a price of ₹168.00 per share.
A pharmaceutical company specializing in the development, manufacturing, and marketing of sterile liquid products for diverse healthcare applications. Incorporated in 1994, the company focuses on producing high-quality injectable formulations and other sterile preparations used across clinical and therapeutic settings. Its distinctive strength lies in specialized expertise in sterile liquid manufacturing processes and a sustained commitment to meeting stringent pharmaceutical quality standards across India's healthcare sector.
Managed by A9 Finsight, with around Rs 360 cr AUM and a top-of-category track record (+233 percent absolute return since July 2023, +132 percent in CY2024 vs CNX Smallcap +24 percent). Allocates ~45 percent to SME listings, ~35 percent to mainboard companies and ~20 percent to pre-IPO. Run by Abhishek Jaiswal, among India's youngest fund managers.
